McKesson's Q2 2024 Earnings: What to Expect
Express News | Mckesson Corp : UBS Raises Target Price to $670 From $630
What's in Store for West Pharmaceutical (WST) in Q2 Earnings?
Barclays Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $596
Barclays analyst Stephanie Davis maintains $McKesson(MCK.US)$ with a buy rating, and maintains the target price at $596.According to TipRanks data, the analyst has a success rate of 42.1% and a
McKesson (MCK) Receives a Buy From Barclays
Investors Appear Satisfied With McKesson Corporation's (NYSE:MCK) Prospects
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may consider McKesson Corporation (NYSE:MCK) as a stock to potentially avoid with its 25
Looking Into McKesson's Recent Short Interest
McKesson's (NYSE:MCK) short percent of float has fallen 10.63% since its last report. The company recently reported that it has 1.85 million shares sold short, which is 1.43% of all regular shares
Express News | Citigroup Maintains Buy on McKesson, Raises Price Target to $670
McKesson Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/19/2024 15.32% Citigroup $620 → $670 Maintains Buy 07/09/2024 13.6% Evercore ISI Group $600 → $660
Citigroup Raises Price Target on McKesson to $670 From $620, Buy Rating Maintained
McKesson (MCK) has an average outperform rating and a price target range of $460 to $700, according to analysts polled by Capital IQ.Price: 579.51, Change: +1.08, Percent Change: +0.19
Citi Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $670
Citi analyst Daniel Grosslight maintains $McKesson(MCK.US)$ with a buy rating, and adjusts the target price from $620 to $670.According to TipRanks data, the analyst has a success rate of 50.4% and
Express News | Mckesson Corp : Citigroup Raises Target Price to $670 From $620
McKesson (MCK) Stock Moves -0.32%: What You Should Know
McKesson, Cardinal, Cencora Interested in Buying Private Cancer Clinics - Report
McKesson (MCK) Gains 26% Year to Date: What's Backing the Rally?
Here's Why McKesson (MCK) Is a Strong Value Stock
Express News | Mckesson Corporation : Morgan Stanley Raises Target Price to $612.00 From $581.00
Morgan Stanley Adjusts Price Target on McKesson to $612 From $581, Maintains Overweight Rating
McKesson (MCK) has an average outperform rating and a price target range of $460 to $700, according to analysts polled by Capital IQ.Price: 597.77, Change: +21.11, Percent Change: +3.66
Morgan Stanley Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $612
Morgan Stanley analyst Erin Wright maintains $McKesson(MCK.US)$ with a buy rating, and adjusts the target price from $581 to $612.According to TipRanks data, the analyst has a success rate of 64.1%
McKesson (MCK) Receives a Buy From Morgan Stanley